Nextech V Oncology Overview
Nextech V Oncology General Information
Description
Nextech V Oncology is a 2018 vintage venture capital fund managed by Nextech Invest. The fund is located in Zurich, Switzerland and invests in the United States and Europe. The fund aims to invest in biotechnology, oncology & life sciences.
Contact Information
Fund Manager's Location
- Bahnhofstrasse 18
- 8001 Zurich
- Switzerland
Nextech V Oncology Investments (11)
Nextech V Oncology has made a total of 11 investments. Its most recent deal was a with Kinnate Biopharma for . The deal was made on 26-Aug-2020.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Kinnate Biopharma | 26-Aug-2020 | Drug Discovery | Startup | |||
| Kronos Bio | 24-Aug-2020 | Biotechnology | Generating Revenue | |||
| PMV Pharma | 17-Jul-2020 | Drug Discovery | Pre-Clinical Trials | |||
| Kinnate Biopharma | 12-Dec-2019 | Drug Discovery | Startup | |||
| Black Diamond Therapeutics | 05-Dec-2019 | Biotechnology | Product Development | |||
| PMV Pharma | 13-Nov-2019 | Drug Discovery | Generating Revenue | |||
| Kronos Bio | 18-Jul-2019 | Biotechnology | Generating Revenue | |||
| Peloton Therapeutics | 20-Feb-2019 | Pharmaceuticals | Generating Revenue | |||
| Black Diamond Therapeutics | 09-Jan-2019 | Early Stage VC (Series B) | Biotechnology | Startup | ||
| Imvision Therapeutics | Early Stage VC | Biotechnology | Startup |
Nextech V Oncology Investment Strategy
Investments by Industry
Investments by Deal Type
Nextech V Oncology Limited Partners (1)
MGB Erisa Master Trust is the sole limited partner of Nextech V Oncology. Its latest Original was on 31-Dec-2017.
| Limited Partner Name | Type | Status | Commitment | Date | Commitment Type |
|---|---|---|---|---|---|
| MGB Erisa Master Trust | Current | 31-Dec-2017 | Original |
Nextech V Oncology Returns Data
The below charts are illustrative of the type of graphical data available to our clients and do not represent live data.
IRR (%)
DPI (x)
RVPI (x)
TVPI (x)
Nextech V Oncology Returns History
| Period | Contribution (by all LPs) | Dry Powder | Distribution (to all LPs) | NAV | Total Fund Distr+NAV | IRR | DPI | RVPI | TVPI | Dry Powder % |
|---|
Nextech V Oncology Benchmark (43)
| Fund Name | Fund Type | Vintage | IRR | Quartile | As of Date |
|---|---|---|---|---|---|
| iTech Fund II | 30-Sep-2021 | ||||
| Katapult Accelerator Fund 2 | |||||
| Crane I | |||||
| Future Planet Capital Fund I | 31-Dec-2024 | ||||
| Inovo Venture Fund II | |||||
| Deepbridge Innovation SEIS Fund | |||||
| IP Fund | |||||
| Aikainen | |||||
| Startup Lab Fund I | |||||
| DCP Direct Investments Fund I |
Nextech V Oncology FAQs
-
What is Nextech V Oncology?
Nextech V Oncology is a 2018 vintage venture capital fund managed by Nextech Invest.
-
Who manages Nextech V Oncology?
Nextech V Oncology is managed by Nextech Invest.
-
Where is Nextech V Oncology domiciled?
Nextech V Oncology is domiciled in Luxembourg.
-
What is Nextech V Oncology's size?
Nextech V Oncology has a size of .
-
What type of fund is Nextech V Oncology?
The fund type of Nextech V Oncology is Venture.
-
What is the status of Nextech V Oncology?
Nextech V Oncology is closed.
-
What has Nextech V Oncology invested in?
Nextech V Oncology has made numerous investments in companies like Kinnate Biopharma, Kronos Bio, and PMV Pharma within the Drug Discovery and Biotechnology industries.
-
What has Nextech V Oncology invested in recently?
Nextech V Oncology's latest investment was on 26-Aug-2020 in Kinnate Biopharma, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
